Literature DB >> 24031299

Antimicrobial resistance in Campylobacter spp isolated from broiler flocks.

Suzete Lora Kuana1, Luciana Ruschel Dos Santos, Laura Beatriz Rodrigues, Anderlise Borsoi, Hamilton Luis do Souza Moraes, Carlos Tadeu Pippi Salle, Vladimir Pinheiro do Nascimento.   

Abstract

The aim of this study was to assess the antimicrobial susceptibility of 62 Campylobacter spp. strains obtained from broiler flocks using the agar diffusion method. The Campylobacter spp strains were isolated from 22 flocks aged between 3 and 5 weeks of life, isolated from cloacae swabs, stools and cecal droppings in the farm and from the carcass rinsing in the slaughterhouse. Campylobacter spp strains were tested on Mueller-Hilton (MH) agar (27 samples) and MH plus TTC agar (35 samples). The antimicrobial susceptibility test revealed a 62.5% resistance to at least one drug, especially to enrofloxacin (71%), neomycin (50%), lincomycin (50%), tetracycline (43%), penicillin (42%), ceftiofur (33%) amoxicillin (27%), spiramycin (20%), ampicillin (18%) and norfloxacin (14%), whereas a lower percentage of strains was resistant to erythromycin (10%) and doxycycline (10%). All strains were sensitive to gentamicin and lincomycin-spectinomycin and 80% of them to colistin. These results indicate that it is necessary to reduce the use of antimicrobials in veterinary and human medicine.

Entities:  

Keywords:  Campylobacter spp; antimicrobial resistance; broiler flocks

Year:  2008        PMID: 24031299      PMCID: PMC3768467          DOI: 10.1590/S1517-838220080004000026

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


INTRODUCTION

Thermophilic bacteria of the genus Campylobacter spp. are foodborne enteric pathogens, and Campylobacter jejuni is the most commonly reported cause of gastroenteritis in humans. The association between Campylobacter in poultry and human enteritis is due to the persistence of this agent in the rearing environment of broilers, which asymptomatically colonizes their intestine and eventually contaminates the carcasses (6). The development of antibiotic resistance in different countries, mainly among zoonotic microorganisms and the impact of foodborne diseases on consumers may be devastating to the food industry (11). The increase in the antimicrobial resistance of Campylobacter may lead to treatment failure in severely affected humans (12). After detecting resistance to fluoroquinolone, Unicomb et al. (12) recommended that this active ingredient should not be used in animals, once resistant Campylobacter may be transmitted to humans by contaminated foods. An increase in the number of ciprofloxacin-resistant Campylobacter strains isolated from pigs, associated with the veterinary use of enrofloxacin, was also reported (1). The strains were isolated from rectal swabs of pigs, from different regions, collected in the slaughterhouse. All ciprofloxacin-resistant strains were also resistant to erythromycin. A similar resistance to erythromycin (63%) was found in C. jejuni and C. coli, suggesting cross-resistance due to the use of tylosin, a drug that also belongs to the macrolide group of antibiotics. In the same study, a high resistance to gentamicin (50%) was found. Nachamkin, Ung and Li (7) submitted Campylobacter strains to E test, and found an MIC equal to or greater than 32 μc/mL which indicates high resistance to fluoroquinolone, and pointed to the fact that this antimicrobial is often used to treat travelers’ diarrhea. Nonetheless, erythromycin resistance was low (<5%). Pedersen and Wederkopp (9) analyzed 10 quinolone resistant Campylobacter strains and obtained six different pulse-field gel electrophoresis (PFGE) patterns, whereas only four different patterns were observed in 12 quinolone susceptible strains. These authors considered the possible existence of new clones or evolution of these variants on the farm, which persisted through several flocks, even in the absence of selection pressure. Therefore, the aim of this study was to assess the in vitro antimicrobial resistance of Campylobacter spp. strains isolated from broilers flocks, focusing on enrofloxacin, a fluoroquinolone approved for veterinary use in Brazil an erythromycin, is used in human clinical medicine, and on 14 other antimicrobials.

MATERIALS AND METHODS

A total of 62 Campylobacter spp strains isolated from 22 flocks aged between 3 and 5 weeks of life were studied, among which 41 were collected on the farm (cloacae swabs, stools and cecal droppings) and 21 in the slaughterhouse (carcasses). Campylobacter spp strains were grown on Mueller-Hilton (MH) agar (27 strains) and MH plus TTC agar (35 strains). The C. jejuni ATCC 33291 reference strain and a C. jejuni IAL2247 field strain were grown on MH plus TTC agar. A suspension of the was cultures was prepared in saline solution (NaCl 0.85%), and turbidity was visually adjusted to the 0.5 McFarland standard (1.5 x 108 cfu/mL). The absorbance of suspension was determined using a spectrophotometer at 630 nm in a flat-bottom microplate. The suspensions were surface plated, within 30 minutes after preparation, and the following antimicrobial disks were applied to the surface of the plates: amoxicillin (10 μg), ampicillin (10 μg), ceftiofur (30 μg), colistin (10 μg), doxycycline (10 μg), enrofloxacin (5 μg), spiramycin (100 ìg), streptomycin (10 μg), erythromycin (15 μg), gentamicin (10 μg), lincomycin-spectinomycin (9/100 μg), lincomycin (2 μg), norfloxacin (10 μg), neomycin (30 μg), penicillin (10 IU) and tetracycline (30 μg). The plates were incubated at 37ºC for 48 hours under microaerophilia (5% O2, 10% CO2, 85% N2), when the inhibition zones around the disks were measured.

RESULTS AND DISCUSSION

The results of antimicrobial resistance of Campylobacter spp. strain isolated from broiler flocks are shown in Table 1. There are no parameters for the susceptibility profile of Campylobacter spp. (2,5), thus the interpretation of results an inhibition zone diameters followed the National Committee for Clinical Laboratory recommendations (8) for microorganisms requiring 5% CO2 for growth. The following bacteria were considered: Enterococcus for penicillin, amoxicillin and ampicillin, Streptococcus for tetracyclines and erythromycin, and Enterobacteriaceae for enrofloxacin. For gentamicin, streptomycin, neomycin and norfloxacin, the interpretations were based on inhibition zone diameter tables for aerobic microorganisms provided by disc suppliers for antibiogram analysis in veterinary and human medicine. The activity of the other antimicrobials (colistin, spiramycin, ceftiofur, lincomycin-spectinomycin, lincomycin) was determined following the recommendation of suppliers for aerobic agents, due to the lack of specific parameters for poultry isolates.
Table 1

Antimicrobial resistance of Campylobacter spp. strains isolated from broiler flocks

Antimicrobial drugNumber of strainsDiameter (mm)S%I%R%
Amoxicillin150–3273027
Ampicillin1214–4482018
Ceftiofur90–24343333
Colistin209–3280200
Doxycycline1012–3090010
Enrofloxacin170–30171271
Erythromycin1011–3090010
Spiramycin1013–30602020
Estreptomicina1410–308604
Gentamicin1123–3010000
Lincomycin-Spectinomycin53110000
Lincomycin120–30173350
Neomycin60–2850050
Norfloxacin140–38721414
Penicilin120–2658042
Tetracycline140–4057043
Antimicrobial resistance of Campylobacter spp. strains isolated from broiler flocks The C. jejuni ATCC 33291 reference strain was resistant to ampicillin and ceftiofur while C. jejuni IAL 2247 strain was susceptible to colistin and lincomycin. It was not possible to measure the activity of the other antimicrobials and the TTC control disc, since there was no growth around the discs. The use of MH agar supplemented with 5% sheep blood (3,5) has been recommended in the literature. MH agar diffusion test compared to agar dilution test was considered to be reliable, easy-to-perform and inexpensive in monitoring the antimicrobial resistance of C. jejuni strains (2). Campylobacter spp. strains evaluated in this study were resistant to at least one antimicrobial (62.5%). The resistance to enrofloxacin (71%), neomycin (50%), tetracycline (43%), lincomycin (50%), penicillin (42%), ceftiofur (33%) amoxicillin (27%), spiramycin (20%), ampicillin (18%) and norfloxacin (14%) was considered high, whereas the resistance to erythromycin and to doxycycline was only 10%. The strains were sensitive to gentamicin (100%), lincomycin-spectinomycin (100%) and colistin (80%). There was high resistance to enrofloxacin and, despite the paucity of previous data on fluoroquinolone susceptibility, this result indicated the persistence of its effects in the environment (9), since enrofloxacin was not used on the poultry farm during this study. In this study, only a small number of strains were resistant to erythromycin, which has been the antimicrobial of choice in Brazil for many cases that require treatment in human medicine (4,5,10). Spiramycin resistance was twice as high. Considerable resistance, to neomycin was detected, possibly due to its sporadic use in the prophylactic treatment of enteroparasitosis in chicken. The unexpected resistance to some unused antimicrobials, such as tetracycline and lincomycin, needs to be further investigated. With regard to penicillin, the beta-lactamase produced by Campylobacter may have contributed towards resistance (2).
  8 in total

1.  A multiplex polymerase chain reaction for the differentiation of Campylobacter jejuni and Campylobacter coli from a swine processing facility and characterization of isolates by pulsed-field gel electrophoresis and antibiotic resistance profiles.

Authors:  Orla M Cloak; Pina M Fratamico
Journal:  J Food Prot       Date:  2002-02       Impact factor: 2.077

2.  Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli.

Authors:  Petra Luber; Edda Bartelt; Elke Genschow; Jutta Wagner; Helmut Hahn
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Development of a selective differential agar for isolation and enumeration of Campylobacter spp.

Authors:  J E Line
Journal:  J Food Prot       Date:  2001-11       Impact factor: 2.077

4.  Microbial profile and antibiotic susceptibility of Campylobacter spp. and Salmonella spp. in broilers processed in air-chilled and immersion-chilled environments.

Authors:  Marcos X Sánchez; Wade M Fluckey; Mindy M Brashears; Shelly R McKee
Journal:  J Food Prot       Date:  2002-06       Impact factor: 2.077

5.  Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level.

Authors:  K Pedersen; A Wedderkopp
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

6.  Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montréal, Canada.

Authors:  Christiane Gaudreau; Huguette Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

7.  Molecular typing of Campylobacter jejuni isolates involved in a neonatal outbreak indicates nosocomial transmission.

Authors:  José Llovo; Estíbaliz Mateo; Angeles Muñoz; María Urquijo; Stephen L W On; Aurora Fernández-Astorga
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

8.  Fluoroquinolone resistance in Campylobacter absent from isolates, Australia.

Authors:  Leanne Unicomb; John Ferguson; Thomas V Riley; Peter Collignon
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

  8 in total
  2 in total

1.  Campylobacter antimicrobial resistance in Peru: a ten-year observational study.

Authors:  Simon Pollett; Claudio Rocha; Rito Zerpa; Lilian Patiño; Augusto Valencia; Máximo Camiña; José Guevara; Martha Lopez; Nancy Chuquiray; Eduardo Salazar-Lindo; Carlos Calampa; Martín Casapia; Rina Meza; Maruja Bernal; Drake Tilley; Michael Gregory; Ryan Maves; Eric Hall; Franca Jones; C Sofia Arriola; Marieke Rosenbaum; Juan Perez; Matthew Kasper
Journal:  BMC Infect Dis       Date:  2012-08-16       Impact factor: 3.090

Review 2.  Antimicrobial Resistance in Farm Animals in Brazil: An Update Overview.

Authors:  Renata F Rabello; Raquel R Bonelli; Bruno A Penna; Julia P Albuquerque; Rossiane M Souza; Aloysio M F Cerqueira
Journal:  Animals (Basel)       Date:  2020-03-26       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.